جستجوی استاد راهنمای دانشگاهی

Edward Kellyمشاهده پروفایل

دانشگاهی

• Toxicology
• Biotechnology
• Drug Metabolism
• +۴ مورد دیگر

Edward Kelly is a Professor and Adjunct Professor at the University of Washington , affiliated with the School of Pharmacy and the Department of Pharmaceutics , as well as the Environmental & Occupational Health Sciences . He is the Co-Director of the Pharmaceutical Bioengineering Program and leads the Kelly Lab , which focuses on microphysiological systems (organs-on-chips) for preclinical toxicology and drug metabolism research. Education : BS, MS, and PhD in Biochemistry from UC Riverside and the University of Washington. His research interests center on ex vivo modeling of human organ physiology and toxicological responses to drugs and xenobiotics, with a focus on liver and kidney ADME organs . His lab is pioneering the use of organs-on-chips to replace animal testing (the 3 Rs) and study disease models and microgravity effects on the International Space Station. His publications highlight the application of microphysiological systems in nephrotoxicity , drug metabolism , and multi-organ coupling . Key themes include toxicology , translational research , and biomedical engineering for preclinical models . Edward Kelly teaches courses such as Biotechnology and Biopharmaceuticals , Drug Disposition Science , and Pharmacokinetics . His lab actively accepts students , and he collaborates with institutions like the Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute and the Program on Pharmacokinetics of Drugs of Abuse during Pregnancy (UWPKDAP) .

Qunzhou Zhangمشاهده پروفایل

دانشگاهی

• Regenerative medicine
• Mesenchymal stem cell biology
• Immunomodulation and anti-inflammation
• +۴ مورد دیگر

Dr. Qunzhou Zhang, PhD, is a Research Assistant Professor in the Department of Oral and Maxillofacial Surgery / Pharmacology at the University of Pennsylvania School of Dental Medicine , Philadelphia, USA, where he has held successive appointments since 2012. He also maintains adjunct/visiting professor affiliations with Guangdong Medical University in China (2008–2016). He earned his doctoral degree in Biochemistry & Molecular Biology from West China University of Medical Sciences (now Sichuan University) in 2000, preceded by an M.Sc. from Guangdong Medical University (1997) and a B.A. in Preventive Medical Sciences from Chongqing Medical College (1990). Dr. Zhang’s research program sits at the intersection of regenerative medicine, stem cell biology, immunomodulation, and cancer . His laboratory focuses on: Immunomodulatory and anti-inflammatory functions of gingiva-derived mesenchymal stem cells (GMSCs) in rodent models of colitis, skin/oral wounds, and allergic dermatitis. Non-genetic induction of neural crest stem-like cells (NCSC) from GMSCs for peripheral nerve regeneration, including 3D bioprinted, scaffold-free nerve grafts . Paracrine mechanisms involving extracellular vesicles (exosomes) secreted by GMSCs that modulate host tissue microenvironments and promote tongue muscle/taste-bud regeneration. Tumor microenvironment studies exploring how mesenchymal stromal cells influence the pathogenesis of ameloblastoma and head & neck squamous cell carcinoma (HNSCC) . Across 50+ peer-reviewed publications since 2004, his work demonstrates a consistent trajectory from basic mechanistic studies to translation-oriented tissue engineering , with particular emphasis on exosome-based therapies and 3D bioprinting technologies . Scientific Awards & Honors Research Support Grant (RSG) , Oral and Maxillofacial Surgery Foundation (2008, 2011, 2014, 2017) Pilot Research Grant , University of Pennsylvania Diabetes Research Center Peter Geistlich Research Award , OsteoScience Foundation (2016) Honored/Adjunct Professor , Guangdong Medical University (2008–2016) Dr. Zhang has served as ad-hoc peer reviewer for more than 25 high-impact journals, including J Invest Dermatol, Stem Cells & Development, Tissue Engineering, PLOS ONE, J Dental Res, Oncotarget and others. While the provided text does not list specific PhD or Master’s students, his role as senior investigator and lab manager implies active mentoring within the university’s research programs. His laboratory is located within the Department of Oral & Maxillofacial Surgery & Pharmacology at Penn Dental Medicine, equipped for in vivo rodent surgery, stem cell culture, 3D bioprinting, and molecular profiling . Future directions include first-in-human trials of GMSC-derived exosome therapeutics and scale-up manufacturing of 3D bioprinted nerve constructs.

Pavak Shahمشاهده پروفایل

استادیار

• Developmental Biology
• Quantitative Imaging
• Cell Fate Regulation
• +۳ مورد دیگر

Pavak Shah is an Assistant Professor in the Department of Molecular, Cell, & Developmental Biology at UCLA's College of Life Sciences. He co-affiliates with the Institute for Quantitative and Computational Biosciences (QCBio). His laboratory develops advanced imaging and computational methods to study fundamental processes in organismal development. Research Focus: Development of Behavior : Maps neuronal circuit emergence in C. elegans embryos using quantitative imaging, genetics, and single-cell manipulations. Temporal Regulation of Cell Fate : Investigates cell cycle timing as a regulatory input for stem cell decisions via genetic perturbations and temperature-controlled microscopy. Evolution of Development : Builds comparative developmental maps across nematode species using machine learning and spatial transcriptomics, developing automated lineage-tracing tools. Publication Trends: Shah's recent work (2020-2025) centers on: 1) Novel microscopy techniques (label-free imaging, traction force microscopy), 2) Quantitative analysis of developmental heterogeneity, 3) Immune cell biomechanics, and 4) Genetic regulators of neural development in C. elegans . His lab consistently pioneers interdisciplinary approaches integrating biophysics, computation, and genetics. Lab & Resources: The Shah Lab focuses on C. elegans models and develops open-source tools for automated cell lineage reconstruction. Collaborative projects utilize microfabricated platforms for cell sorting and analysis.

Craig C. Malbonمشاهده پروفایل

استاد

• Signal Transduction
• Molecular Scaffold Biology
• Wnt Signaling Pathways
• +۶ مورد دیگر

Craig C. Malbon is a Leading Professor at Stony Brook University's School of Medicine, holding primary appointments in the Department of Pharmacological Sciences and secondary affiliation with the Department of Family, Population & Preventive Medicine. He directs an active research laboratory established in 1978 and serves as Director-emeritus of the NIH-funded Diabetes & Metabolic Diseases Research Program (1986-2015). Ph.D. in Pharmacology from Case Western Reserve University Postdoctoral training at Brown University and Harvard University M.Div. in Ethics from Union Theological Seminary Visiting Scholar at Princeton Theological Seminary His research focuses on signal transduction mechanisms in development and disease, specializing in molecular scaffold proteins (Dishevelleds and AKAPs) that organize signaling complexes. His laboratory employs advanced techniques including fluorescence correlation spectroscopy, proteomics, and live-cell imaging to study Wnt signaling and GPCR regulation. His 290+ publications reveal consistent emphasis on spatiotemporal aspects of cellular signaling with applications to cancer, metabolic disorders, and developmental biology. Recent work increasingly integrates his dual expertise through investigations into consciousness, moral formation, and bioethics failures . Recipient of the American Cancer Society Research Award (1997) Top 10 Researchers recognition (1990-2000) Goodman & Gilman Award from ASPET (2008) Fellow of AAAS (2008) Overseas Fellow, Royal Society of Medicine (2015) As an ethicist and ordained United Church of Christ minister, he directs bioethics training within NIH postdoctoral programs and has authored three books: Abortion in 21st Century America (2013), Assaulted Personhood (2021), and GUN-AMERICA (2022). His laboratory has trained over 75 doctoral students and 100 NIH fellows through the NIDDK-funded program, with alumni pursuing careers in academia, industry, and clinical research.

Chi-Lien Chengمشاهده پروفایل

استاد

• Plant Developmental Biology
• Plant Genetics
• Evolutionary Developmental Biology
• +۱ مورد دیگر

Chi-Lien Cheng is a Professor in the Department of Biology at the University of Iowa, where she investigates fundamental mechanisms of plant development with emphasis on alternation of generations in land plants and vegetative phase change in maize. Her research program leverages the model fern Ceratopteris richardii to dissect asexual life cycle transitions and identify evolutionarily conserved genetic pathways. Education: PhD, University of Connecticut Dr. Cheng's research integrates genetics, molecular biology, and evolutionary perspectives to understand how plants regulate developmental transitions across generations. Her laboratory focuses on molecular mechanisms controlling gametophyte-sporophyte switching in ferns and phase change in maize, utilizing genomic, transcriptomic, and functional approaches to elucidate conserved regulatory networks. This work provides critical insights into the evolution of developmental processes from non-seed to seed plants. Analysis of her 15 most recent publications (2018-2025) reveals three dominant research trajectories: (1) WOX gene family evolution and function in fern gametophyte development, (2) hormonal and epigenetic regulation of vegetative phase change in maize, and (3) molecular adaptation mechanisms in mangroves under environmental stress. Her publications consistently bridge model systems—from ferns to maize to mangroves—demonstrating how comparative approaches uncover universal principles in plant development. Dr. Cheng leads an active research laboratory that pioneered transformation techniques for Ceratopteris gametophytes, enabling genetic dissection of asexual reproduction pathways. Her team's identification of key genes in apogamy and apospory provides foundational knowledge for understanding apomixis in crop plants, with potential applications for agricultural innovation through clonal seed production.

• Regeneration and Stem Cells
• Disease Mechanisms and Therapeutics
• Retinal Biology
• +۳ مورد دیگر

Timothy A Blenkinsop is an Associate Professor at the Icahn School of Medicine at Mount Sinai , affiliated with the Department of Ophthalmology and Cell, Developmental & Regenerative Biology . His research focuses on retinal regeneration, particularly the biology of the retinal pigment epithelium (RPE) , with an emphasis on developing in vitro disease models, epigenetic profiling, and transplantation strategies for RPE-related pathologies. Education: PhD in Developmental Biology, New York University BS in Cell Biology, University of Wisconsin at Whitewater His work bridges regenerative medicine and translational ophthalmology , with key contributions to understanding RPE dysfunction in diseases like Age-Related Macular Degeneration (AMD) and Proliferative Vitreoretinopathy (PVR) . Recent publications highlight advancements in stem cell-derived RPE therapy, contractility inhibition, and viral ocular infection models. Dr. Blenkinsop's laboratory develops 3D eye organoids , epigenetic profiling tools , and NRF2 signaling modulators to address retinal degeneration. His research has implications for therapeutic development, including preclinical models and biofunctional polymers to prevent retinal scarring. Office Location: Annenberg Building, Floor 22, Room A22-08, 1468 Madison Ave, New York, NY 10029 .

Janine Reichenbachمشاهده پروفایل

استاد

• Somatic Gene Therapy
• Primary Immunodeficiencies
• Hematopoietic Stem Cell Research
• +۴ مورد دیگر

Prof. Dr. med. Janine Reichenbach is a full professor and head of the Somatic Gene Therapy department at the University of Zurich, affiliated with the University Children's Hospital Zurich. She holds dual board certifications in Pediatrics and Adolescent Medicine (Germany/Switzerland) and Allergology & Clinical Immunology (Switzerland). Her career spans over two decades of translational research bridging basic science and clinical implementation of gene therapies. Education: MD from Goethe University Frankfurt (1995-1997), medical training in Germany (1997-2000), and specialist certifications in Switzerland (2005-2009). Research Focus: Translational development of hematopoietic stem cell-based gene therapies for primary immunodeficiencies, particularly chronic granulomatous disease (CGD) and ataxia telangiectasia (A-T). Key projects include lentiviral vector design, genome editing at ATM locus, and myeloid-targeted therapies with brain-crossing potential. Awards: Recipient of the 2010 Walther und Gertrud Siegenthaler Stiftung prize. Grants: Leads Swiss National Science Foundation projects, University Research Priority Programs (URPP Itinerare), Clinical Research Priority Programs (CRPP ImmuGene), and Wyss Centre collaborations. Leadership: Principal investigator in EU-FP7 projects CELL-PID and NET4CGD, steering committee member for SCID newborn screening, and co-founder of international research networks.

Maoli Duanمشاهده پروفایل

دانشیار

• Otolaryngology
• Gene Therapy
• Stem Cell Therapy
• +۳ مورد دیگر

Maoli Duan is an Associate Professor and Senior Consultant at the Karolinska Institutet , affiliated with the Department of Clinical Science, Intervention and Technology under the Ear, Nose and Throat Diseases division. With over 150 peer-reviewed publications, his translational research bridges animal models and clinical applications in otolaryngology. Academic Rank: Associate Professor (Karolinska Institutet, 2006) Doctoral Degree: Department of Physiology and Pharmacology, Karolinska Institutet (1999) Research Focus Dr. Duan's work centers on gene therapy and stem cell treatments for sensorineural hearing loss , with recent breakthroughs in AAV vector delivery for congenital deafness. His 2025 Nature Medicine study demonstrated hearing restoration in patients with OTOF gene mutations through viral gene replacement. Publication Trends His 15 most recent articles (2023-2025) span biomedical engineering , clinical otology , and translational neuroscience . Key subfields include inner ear drug delivery , cochlear implants , gene therapy protocols , and viral vector optimization . Notably, his team has pioneered non-invasive approaches to treating Meniere's disease and noise-induced hearing loss . Collaborative Networks Dr. Duan collaborates with institutions across Europe , Asia , and North America , with recurring co-authors from Karolinska Institutet , University of Gothenburg , and Shanghai Jiao Tong University . His work appears in Nature Medicine , PNAS , and Advanced Science . Scientific Context Dr. Duan's research aligns with global efforts to address genetic hearing disorders through molecular interventions. His team's clinical trials demonstrate that gene therapy can restore near-normal hearing in OTOF mutation carriers without major adverse events, opening new pathways for non-invasive auditory restoration in both pediatric and adult populations.

Xiaojun Lance Lianمشاهده پروفایل

دانشیار

• Stem Cell Research
• Bioengineering
• Molecular Biology
• +۳ مورد دیگر

Xiaojun Lance Lian is an Associate Professor in Biomedical Engineering at Penn State University, holding affiliations with the Penn State Cancer Institute, Huck Institutes of the Life Sciences, and Center for Neural Engineering. His research spans stem cell bioengineering, CRISPR technology, and regenerative medicine. Recent research trends highlight work in Bioprinting optoelectronically active cardiac tissues CRISPR-mediated immunoengineering for cardiac therapy ModRNA-based direct programming of stem cells Development of lineage-specific reporter systems Scientific awards and grants include National Science Foundation CAREER Award National Institute of Diabetes and Digestive and Kidney Diseases funding National Science Foundation RNA sensing platform development National Institute of Biomedical Imaging and Bioengineering grants His work contributes to UN Sustainable Development Goals through advancements in stem cell therapies and biomedical technologies. Collaborations extend to international research networks in stem cell differentiation and gene editing.

• Liver Disease Research
• Stem Cell Biology
• Cellular Spheroid Technology
• +۴ مورد دیگر

Laura Cools is a PhD candidate and Researcher at the Faculty of Medicine and Pharmacy , Vrije Universiteit Brussel, affiliated with the Basic Biomedical Sciences department. Her work focuses on liver disease modeling using advanced cellular technologies. Research interests center on Liver fibrosis mechanisms iPSC-derived spheroid systems Non-alcoholic fatty liver disease (NAFLD/NASH) Hepatic stellate cell biology 3D in vitro tissue engineering Scientific achievements include the Best video award at the IC3Rs symposium (2022) Laura actively collaborates with international teams on liver disease models, as evidenced by her presentations at conferences (2021-2024). Her research emphasizes the development of human and mouse-derived spheroid systems for fibrosis and metabolic disease studies.

Sabine A. Fuchsمشاهده پروفایل

استاد

• Metabolic Diseases
• Genetic Diseases
• Pediatrics
• +۵ مورد دیگر

Sabine A. Fuchs is a Full Professor and pediatrician specializing in metabolic diseases at Utrecht University Medical Center (UMC-Utrecht), holding a Principal Investigator position at the Hubrecht Institute's Regenerative Medicine and Stem Cell Research group (RMCU). Her dual clinical-research role bridges patient care with translational science in pediatric genetic disorders. Her academic journey includes cum laude degrees in Pharmacy and Medicine from Utrecht University, supplemented by research in Edinburgh (Prof. Webb) and clinical training at Harvard Medical School. She completed pediatric specialization alongside a ZonMW AGIKO-funded PhD in metabolic diseases, later establishing her independent research line through a ZonMW Klinische Fellows grant. Dr. Fuchs' research centers on metabolic and genetic diseases in children, with emphasis on mitochondrial disorders and inborn errors of metabolism. She pioneers mRNA-based therapeutics, in vivo gene correction, and mitochondrial function restoration, developing innovative platforms like liver organoids for disease modeling. Her work integrates clinical insights with molecular diagnostics to address unmet therapeutic needs. Recent publications reveal strong trends in mRNA delivery systems for genetic diseases, aminoacyl-tRNA synthetase deficiency treatments, and advanced cellular screening for variant interpretation. Her group's work on mitochondrial phenotyping and amino acid metabolism demonstrates a multidisciplinary approach spanning nanomedicine, stem cell biology, and metabolic engineering. Her 2024 awards include: €200,000 Biotech Booster grant for HeLLO €150,000 ERC Proof of Concept grant for IMPACT €1.5 million ZonMW VICI grant for in vivo gene correction €15,000 Tjallingh Roorda Stichting grant for mitochondrial disease therapies Dr. Fuchs supervises PhD candidates through grants like the Tjallingh Roorda project and leads collaborative research funded by ZonMW, ERC, and Dutch foundations. Her grants portfolio exceeds €2 million in 2024, supporting translational pipelines from basic discovery to clinical application. She directs a research team within the RMCU at the Hubrecht Institute, collaborating with UMC-Utrecht clinicians and international partners to advance regenerative medicine approaches for childhood metabolic disorders through stem cell models and gene editing technologies.

Juan Alonso-Serraمشاهده پروفایل

پژوهشگر

• Plant Biology
• Molecular Biology
• Biochemistry
• +۴ مورد دیگر

Juan Alonso-Serra is a University Researcher at the Organismal and Evolutionary Biology Research Program within the Faculty of Biological and Environmental Sciences at the University of Helsinki. His work integrates molecular, cellular, and organismal approaches to investigate fundamental mechanisms in plant development and environmental adaptation. His research focuses on plant biomechanics, molecular signaling, and evolutionary biology, with specific expertise in turgor pressure dynamics, cell wall architecture, and hormonal regulation of growth. Key investigations include water flux patterns in meristems, callose deposition in woody tissues, auxin-strigolactone crosstalk in tree architecture, and carbon sequestration feedback mechanisms. This interdisciplinary work bridges biochemistry, biophysics, and systems biology to unravel how mechanical and biochemical pathways co-regulate plant morphogenesis. Analysis of his 2021-2024 publications reveals a dominant theme in plant mechanobiology, where turgor-driven processes interact with molecular signaling to shape organ development. His studies employ advanced techniques including nano-architecture imaging, mutant phenotyping, and computational modeling, with consistent emphasis on translating cellular-scale mechanisms to whole-plant architectural outcomes. Recurring subfields include meristem function, cell wall dynamics, and hormone gradient formation across diverse plant systems. Dr. Alonso-Serra currently participates in the Horizon Europe-funded project Uncovering turgor sensing in the Arabid (2024-2026), supporting his research on mechanical force transduction in plant cells. While no formal student advising is documented, his collaborative network spans 14+ international institutions as evidenced by multi-author publications in high-impact journals including Nature Communications and PNAS .

Andrea D. Mergمشاهده پروفایل

استادیار

• Peptide Chemistry
• Materials Chemistry
• Supramolecular Chemistry
• +۵ مورد دیگر

Andrea D. Merg is an Assistant Professor in the Department of Chemistry and Biochemistry within the School of Natural Sciences at the University of California, Merced. He leads the Merg Lab, which focuses on the design and fabrication of nanoscale materials derived from the self-assembly of sequence-programmable biomolecules including peptides, proteins, and nucleic acids. Dr. Merg received his B.S. in Chemistry from Winthrop University in 2010, completed his Ph.D. at the University of Pittsburgh in 2017 working on peptide-based methods for directing gold nanoparticles, and conducted postdoctoral research at Emory University until 2020. His research spans multiple disciplines including peptide chemistry, materials chemistry, supramolecular chemistry, materials science, and bioengineering. The Merg Lab develops rational approaches for creating bionanomaterials with predetermined physical and chemical properties, with applications in biosensors, drug delivery, and catalysis. Their work addresses the outstanding challenge of developing supramolecular architectures with hierarchical physical and chemical control across length-scales. Analysis of Dr. Merg's recent publications reveals a strong focus on peptide-based nanomaterials, particularly collagen-mimetic structures and coiled coil peptide assemblies. His research demonstrates expertise in creating programmable biomolecular building blocks that enable precise control over nanoscale architecture formation. The work combines synthetic chemistry, biophysical characterization, and computational modeling to understand and design novel biomaterials. NSF grant CHE-2316870 for fundamental research ARO grant W911NF-23-1-0365 NSF grant for developing aCMP frameworks NSF-CREST fellowship supporting graduate student Anthony R. Perez Dr. Merg actively mentors graduate and undergraduate students, with Anthony R. Perez being the first Ph.D. student to successfully defend his dissertation in the Merg Lab. The lab maintains strong outreach efforts, including visits to local high schools to promote STEM careers. Current research directions include developing mesoporous peptide frameworks, expanding the coiled coil assembly toolkit, and engineering shape-shifting peptide nanomaterials with responsive properties.

• Plant Biotechnology
• Genetic Engineering
• Biochemical Engineering
• +۳ مورد دیگر

Dr. Jianfeng (Jay) Xu is a Professor of Biochemical Engineering at Arkansas State University's Beck College of Sciences & Mathematics, Department of Molecular Biosciences. He holds a Ph.D. and B.S. in Biochemical and Environmental Engineering from Dalian University of Technology, China. Education: Ph.D., Dalian University of Technology, China (Biochemical Engineering) B.S., Dalian University of Technology, China (Environmental Engineering) His research focuses on plant-based bioproduction platforms using genetic engineering and genome editing to enhance therapeutic protein and biofuel yields. He developed the "HypGP Engineering" technology, enabling over 500-fold protein yield increases in plant systems. Applications include oral medications for inflammatory bowel disease and bioenergy crop modifications for improved biomass digestibility. Recent publications emphasize plant cell engineering for therapeutic proteins, glycosylation optimization, biomass processing, and biomedical applications. His work has received federal funding from NIH, NSF, USDA, and DOE. Scientific contributions include 8 issued U.S. patents related to plant glycoprotein production and expression systems. Grants: National Institutes of Health (NIH) National Science Foundation (NSF) United States Department of Agriculture (USDA) Department of Energy (DOE) Patents: Growth hormone and interferon-alpha-2 glycoproteins in plants Designer glycomodules for protein expression Methods for hyp-glycosylation site prediction Dr. Xu leads the Xu Lab, pioneering plant cell systems for biopharmaceuticals and sustainable biofuels. His lab investigates macromolecular crowding effects, cell wall reconstruction, and recombinant protein trafficking mechanisms.

Changchun Zengمشاهده پروفایل

استاد

• Polymeric Materials
• Nanomaterials
• Composite Materials
• +۳ مورد دیگر

Changchun Zeng serves as Chair and Professor of Industrial and Manufacturing Engineering at the FAMU-FSU College of Engineering, a joint institution between Florida A&M University and Florida State University. His leadership spans academic administration and cutting-edge research in advanced materials science. He earned his Ph.D. from Ohio State University in 2004, establishing a foundation for his interdisciplinary work bridging polymer engineering and biomedical applications. His educational background underpins his innovative approach to materials design and manufacturing. Dr. Zeng's research centers on Polymeric Materials, Nanomaterials, and Composite Materials with pronounced emphasis on biomaterials for tissue engineering. His lab pioneers organoid-based models and extracellular vesicle technologies, developing auxetic scaffolds that regulate stem cell differentiation through mechanical and viscoelastic cues. Recent work integrates piezoresistive sensor design with neural and vascular applications, demonstrating translational potential for neuropathy treatments. Analysis of his 2023-2025 publications reveals three dominant trends: (1) Extracellular vesicle engineering from blood vessel and brain organoids for anti-senescence and neuropathy applications; (2) Development of auxetic foams and scaffolds with precisely controlled mechanical properties for tissue regeneration; (3) Advanced piezoelectret sensors leveraging cyclic olefin copolymers for flexible electronics. These intersect biomaterials, stem cell biology, and polymer physics to address unmet needs in regenerative medicine. Dr. Zeng actively mentors graduate students in the Industrial and Manufacturing Engineering program, supervising research in bioreactor design, stem cell-material interactions, and advanced manufacturing processes. His laboratory secures continuous funding for projects spanning NSF and NIH domains, particularly in biomaterials development and organoid-based disease modeling. The research group operates state-of-the-art facilities for polymer processing, nanomaterial characterization, and 3D bioprinting. Current team efforts focus on vertical wheel bioreactors for extracellular vesicle production, surface-engineered scaffolds for spinal cord regeneration, and piezoresistive sensor arrays for neural monitoring.